Cambridge Nutritional Sciences Plc (ODX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kromek Group Plc

Cambridge Nutritional Sciences Plc

Surgical Innovations Group Plc

Polarean Imaging Plc

NetScientific Plc

Inspiration Healthcare Group Plc

MyHealthChecked Plc

Abingdon Health Plc

Proteome Sciences Plc

Tissue Regenix Group Plc

Genedrive Plc

Why is Cambridge Nutritional Sciences Plc ?

PRE-TAX PROFIT(Q) At GBP -0.26 MM has Fallen at -227.85%
NET PROFIT(Q) At GBP -0.26 MM has Fallen at -227.85%
CASH AND EQV(HY) Lowest at GBP 3.59 MM

With ROE of -4.03%, it has a very attractive valuation with a 0.41 Price to Book Value

Over the past year, while the stock has generated a return of -37.70%, its profits have fallen by -69%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -37.70% returns in the last 1 year, the stock has also underperformed FTSE 100 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Cambridge Nutritional Sciences Plc should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cambridge Nutritional Sciences Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cambridge Nutritional Sciences Plc

-37.7%

-1.26

44.17%

FTSE 100

13.98%

1.15

13.60%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.10%

EBIT Growth (5y)

8.93%

EBIT to Interest (avg)

-1.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.47

Sales to Capital Employed (avg)

0.72

Tax Ratio

41.70%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.14%

ROE (avg)

2.47%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.41

EV to EBIT

-1.09

EV to EBITDA

-1.09

EV to Capital Employed

0.14

EV to Sales

0.14

PEG Ratio

Dividend Yield

ROCE (Latest)

-11.68%

ROE (Latest)

-4.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

OPERATING CASH FLOW(Y)

Highest at GBP 0.58 MM

NET PROFIT(HY)

Higher at GBP -0.26 MM

RAW MATERIAL COST(Y)

Fallen by -6.27% (YoY

-9What is not working for the Company

PRE-TAX PROFIT(Q)

At GBP -0.26 MM has Fallen at -227.85%

NET PROFIT(Q)

At GBP -0.26 MM has Fallen at -227.85%

CASH AND EQV(HY)

Lowest at GBP 3.59 MM

DEBT-EQUITY RATIO (HY)

Highest at -30.37 %

NET SALES(Q)

Lowest at GBP 3.86 MM

Here's what is working for Cambridge Nutritional Sciences Plc

Operating Cash Flow

Highest at GBP 0.58 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Raw Material Cost

Fallen by -6.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cambridge Nutritional Sciences Plc

Pre-Tax Profit

At GBP -0.26 MM has Fallen at -227.85%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (GBP MM)

Net Profit

At GBP -0.26 MM has Fallen at -227.85%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (GBP MM)

Net Sales

Lowest at GBP 3.86 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (GBP MM)

Cash and Eqv

Lowest at GBP 3.59 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -30.37 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio